{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:12:49Z","timestamp":1770217969227,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T00:00:00Z","timestamp":1245628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Glomerular microthrombosis (GMT) is a common vascular change in patients with lupus nephritis (LN). The mechanism underlying GMT is largely unknown. Although several studies have reported the association of antiphospholipid antibodies (aPL) with GMT, the relation between GMT and aPL remains controversial. Previous studies have demonstrated that some aPL could bind to several hemostatic and fibrinolytic proteases that share homologous enzymatic domains. Of the protease-reactive aPL, some can inhibit the anticoagulant activity of activated protein C and the fibrinolytic function of plasmin, and hinder the antithrombin inactivation of thrombin. The purpose of this study was to investigate the prevalence of GMT in LN patients and examine the relation between the aPL profiles (including some protease-reactive aPL) and GMT.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Renal biopsy specimens were examined for the presence of glomerular microthrombi. Plasma samples from 25 LN patients with GMT (LN-GMT group) and 99 LN patients without GMT (LN-non-GMT group) were tested for lupus anticoagulant and antibodies against cardiolipin, \u03b22 glycoprotein I, plasmin, thrombin, tissue plasminogen activator, and annexin II.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>The prevalence of GMT in LN patients was 20.2%. Compared with the LN-non-GMT group, the LN-GMT group had an elevated systemic lupus erythematosus disease activity index; elevated renal tissue injury activity and chronicity indices; elevated serum creatinine, blood urea nitrogen, and proteinuria levels; a lower serum C3 level and much intense glomerular C3, C1q staining; and a higher frequency of hypertension (<jats:italic>P<\/jats:italic> &lt; 0.05 for all). Additionally, the detection rate of lupus anticoagulant, immunoglobulin G (IgG) anti-\u03b22 glycoprotein I and anti-thrombin antibodies were higher in the LN-GMT group than in the LN-non-GMT group (<jats:italic>P<\/jats:italic> &lt; 0.05 for all). No statistical differences were found in the detection rates of IgG anti-cardiolipin, plasmin, tissue plasminogen activator, or annexin II antibodies (<jats:italic>P<\/jats:italic> &gt; 0.05 for all). No detectable difference in IgM autoantibodies to the above antigens was observed between the two groups.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>GMT occurs in approximately 20.2% of LN patients. Patients with GMT have severer renal tissue injuries and poorer renal functions than patients without GMT. The lupus anticoagulant and antibodies against \u03b22 glycoprotein I and thrombin may play a role in GMT.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2736","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T06:15:28Z","timestamp":1245737728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases"],"prefix":"10.1186","volume":"11","author":[{"given":"Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-cheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-de","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,22]]},"reference":[{"key":"2576_CR1","volume-title":"Dubois' lupus erythematosus","author":"DJ Wallace","year":"2007","unstructured":"Wallace DJ, Hahn BH: Dubois' lupus erythematosus. 2007, Baltimore: Lippincott, Williams & Wilkins, 7","edition":"7"},{"key":"2576_CR2","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJM199406303302608","volume":"330","author":"JA Mills","year":"1994","unstructured":"Mills JA: Systemic lupus erythematosus. N Engl J Med. 1994, 330: 1871-1879. 10.1056\/NEJM199406303302608.","journal-title":"N Engl J Med"},{"key":"2576_CR3","first-page":"S120","volume":"23","author":"GK Lam","year":"2005","unstructured":"Lam GK, Petri M: Assessment of systemic lupus erythematosus. Clin Exp Rheumatol. 2005, 23: S120-132.","journal-title":"Clin Exp Rheumatol"},{"key":"2576_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00005792-198103000-00001","volume":"60","author":"KS Kant","year":"1981","unstructured":"Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller AN, Hess EV: Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore). 1981, 60: 71-86.","journal-title":"Medicine (Baltimore)"},{"key":"2576_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/096120339400300106","volume":"3","author":"JM Miranda","year":"1994","unstructured":"Miranda JM, Garcia-Torres R, Jara LJ, Medina F, Cervera H, Fraga A: Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus. 1994, 3: 25-29. 10.1177\/096120339400300106.","journal-title":"Lupus"},{"key":"2576_CR6","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM: Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum. 2004, 50: 2569-2579. 10.1002\/art.20433.","journal-title":"Arthritis Rheum"},{"key":"2576_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/qjmed\/91.6.401","volume":"91","author":"S Bhandari","year":"1998","unstructured":"Bhandari S, Harnden P, Brownjohn AM, Turney JH: Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. QJM. 1998, 91: 401-409. 10.1093\/qjmed\/91.6.401.","journal-title":"QJM"},{"key":"2576_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","volume":"13","author":"E Daugas","year":"2002","unstructured":"Daugas E, Nochy D, Huong DL, Duhaut P, Beaufils H, Caudwell V, Bariety J, Piette JC, Hill G: Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol. 2002, 13: 42-52.","journal-title":"J Am Soc Nephrol"},{"key":"2576_CR9","first-page":"795","volume":"68","author":"P Kincaid-Smith","year":"1988","unstructured":"Kincaid-Smith P, Fairley KF, Kloss M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med. 1988, 68: 795-815.","journal-title":"Q J Med"},{"key":"2576_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0272-6386(12)70258-5","volume":"20","author":"E Farrugia","year":"1992","unstructured":"Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE: Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis. 1992, 20: 463-471.","journal-title":"Am J Kidney Dis"},{"key":"2576_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000188671","volume":"71","author":"M Perdiguero","year":"1995","unstructured":"Perdiguero M, Boronat M, Marco P, Rivera F: The role of antiphospholipid antibodies in lupus nephropathy. Nephron. 1995, 71: 35-39. 10.1159\/000188671.","journal-title":"Nephron"},{"key":"2576_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/oxfordjournals.ndt.a027822","volume":"13","author":"F Bridoux","year":"1998","unstructured":"Bridoux F, Vrtovsnik F, Noel C, Saunier P, Mougenot B, Lemaitre V, Dracon M, Lelievre G, Vanhille P: Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long-term renal survival. Nephrol Dial Transplant. 1998, 13: 298-304. 10.1093\/ndt\/13.2.296.","journal-title":"Nephrol Dial Transplant"},{"key":"2576_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4: 295-306. 10.1111\/j.1538-7836.2006.01753.x.","journal-title":"J Thromb Haemost"},{"key":"2576_CR14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ndt\/4.10.854","volume":"4","author":"D Kleinknecht","year":"1989","unstructured":"Kleinknecht D, Bobrie G, Meyer O, Noel LH, Callard P, Ramdane M: Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant. 1989, 4: 854-858.","journal-title":"Nephrol Dial Transplant"},{"key":"2576_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ki.1991.155","volume":"39","author":"G Frampton","year":"1991","unstructured":"Frampton G, Hicks J, Cameron JS: Significance of anti-phospholipid antibodies in patients with lupus nephritis. Kidney Int. 1991, 39: 1225-1231. 10.1038\/ki.1991.155.","journal-title":"Kidney Int"},{"key":"2576_CR16","first-page":"481","volume":"31","author":"S Wakai","year":"1991","unstructured":"Wakai S, Matsumura O, Koike T, Maruyama N, Yumura W: Anti-cardiolipin antibody and renal microthrombi in lupus nephritis. Ryumachi. 1991, 31: 481-487.","journal-title":"Ryumachi"},{"key":"2576_CR17","first-page":"725","volume":"151","author":"K Yamamoto","year":"1997","unstructured":"Yamamoto K, Loskutoff DJ: The kidneys of mice with autoimmune disease acquire a hypofibrinolytic\/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol. 1997, 151: 725-734.","journal-title":"Am J Pathol"},{"key":"2576_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000013615","volume":"20","author":"IP Naiker","year":"2000","unstructured":"Naiker IP, Rughubar KN, Duursma J, Pudifin DJ, Seedat YK: Anticardiolipin antibodies in South African patients with lupus nephritis: a clinical and renal pathological study. Am J Nephrol. 2000, 20: 351-357. 10.1159\/000013615.","journal-title":"Am J Nephrol"},{"key":"2576_CR19","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/art.23662","volume":"58","author":"D Cohen","year":"2008","unstructured":"Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, Roos van Groningen M, Steup-Beekman GM, de Heer E, Bruijn JA, Bajema IM: Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008, 58: 2460-2469. 10.1002\/art.23662.","journal-title":"Arthritis Rheum"},{"key":"2576_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-199709000-00003","volume":"76","author":"E Descombes","year":"1997","unstructured":"Descombes E, Droz D, Drouet L, Grunfeld JP, Lesavre P: Renal vascular lesions in lupus nephritis. Medicine (Baltimore). 1997, 76: 355-368. 10.1097\/00005792-199709000-00003.","journal-title":"Medicine (Baltimore)"},{"key":"2576_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/art.22598","volume":"56","author":"R Gong","year":"2007","unstructured":"Gong R, Liu Z, Li L: Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental\/clinical factors. Arthritis Rheum. 2007, 56: 1608-1617. 10.1002\/art.22598.","journal-title":"Arthritis Rheum"},{"key":"2576_CR22","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.4049\/jimmunol.167.12.7192","volume":"167","author":"KK Hwang","year":"2001","unstructured":"Hwang KK, Grossman JM, Visvanathan S, Chukwuocha RU, Woods VL, Le DT, Hahn BH, Chen PP: Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol. 2001, 167: 7192-7198.","journal-title":"J Immunol"},{"key":"2576_CR23","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.4049\/jimmunol.172.9.5765","volume":"172","author":"CD Yang","year":"2004","unstructured":"Yang CD, Hwang KK, Yan W, Gallagher K, FitzGerald J, Grossman JM, Hahn BH, Chen PP: Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J Immunol. 2004, 172: 5765-5773.","journal-title":"J Immunol"},{"key":"2576_CR24","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/art.21485","volume":"52","author":"CS Lu","year":"2005","unstructured":"Lu CS, Horizon AA, Hwang KK, FitzGerald J, Lin WS, Hahn BH, Wallace DJ, Metzger AL, Weisman MH, Chen PP: Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum. 2005, 52: 4018-4027. 10.1002\/art.21485.","journal-title":"Arthritis Rheum"},{"key":"2576_CR25","doi-asserted-by":"publisher","first-page":"15541","DOI":"10.1074\/jbc.275.20.15541","volume":"275","author":"K Ma","year":"2000","unstructured":"Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR: High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000, 275: 15541-15548. 10.1074\/jbc.275.20.15541.","journal-title":"J Biol Chem"},{"key":"2576_CR26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","volume":"81","author":"JD Oosting","year":"1993","unstructured":"Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood. 1993, 81: 2618-2625.","journal-title":"Blood"},{"key":"2576_CR27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","volume":"47","author":"J Nojima","year":"2001","unstructured":"Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y: Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem. 2001, 47: 1008-1015.","journal-title":"Clin Chem"},{"key":"2576_CR28","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.4049\/jimmunol.177.11.8219","volume":"177","author":"YH Yang","year":"2006","unstructured":"Yang YH, Hwang KK, FitzGerald J, Grossman JM, Taylor M, Hahn BH, Chen PP: Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin. J Immunol. 2006, 177: 8219-8225.","journal-title":"J Immunol"},{"key":"2576_CR29","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/art.10983","volume":"48","author":"KK Hwang","year":"2003","unstructured":"Hwang KK, Yang CD, Yan W, Grossman JM, Hahn BH, Chen PP: A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arthritis Rheum. 2003, 48: 1622-1630. 10.1002\/art.10983.","journal-title":"Arthritis Rheum"},{"key":"2576_CR30","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","volume":"107","author":"G Cesarman-Maus","year":"2006","unstructured":"Cesarman-Maus G, Rios-Luna NP, Deora AB, Huang B, Villa R, Cravioto Mdel C, Alarcon-Segovia D, Sanchez-Guerrero J, Hajjar KA: Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 2006, 107: 4375-4382. 10.1182\/blood-2005-07-2636.","journal-title":"Blood"},{"key":"2576_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1177\/0961203308092805","volume":"17","author":"PP Chen","year":"2008","unstructured":"Chen PP, Yang CD, Ede K, Wu CC, FitzGerald JD, Grossman JM: Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis. Lupus. 2008, 17: 916-921. 10.1177\/0961203308092805.","journal-title":"Lupus"},{"key":"2576_CR32","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1725-10.1002\/art.1780400928.","journal-title":"Arthritis Rheum"},{"key":"2576_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004, 15: 241-250. 10.1097\/01.ASN.0000108969.21691.5D.","journal-title":"J Am Soc Nephrol"},{"key":"2576_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ki.1984.75","volume":"25","author":"HA Austin 3rd","year":"1984","unstructured":"Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984, 25: 689-695. 10.1038\/ki.1984.75.","journal-title":"Kidney Int"},{"key":"2576_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/qjmed\/93.7.457","volume":"93","author":"MH Griffiths","year":"2000","unstructured":"Griffiths MH, Papadaki L, Neild GH: The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial injury. QJM. 2000, 93: 457-467. 10.1093\/qjmed\/93.7.457.","journal-title":"QJM"},{"key":"2576_CR36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","volume":"10","author":"D Nochy","year":"1999","unstructured":"Nochy D, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC, Bariety J, Hill G: The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999, 10: 507-518.","journal-title":"J Am Soc Nephrol"},{"key":"2576_CR37","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1046\/j.1523-1755.2002.00500.x","volume":"62","author":"CM Nzerue","year":"2002","unstructured":"Nzerue CM, Hewan-Lowe K, Pierangeli S, Harris EN: \"Black swan in the kidney\": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 2002, 62: 733-744. 10.1046\/j.1523-1755.2002.00500.x.","journal-title":"Kidney Int"},{"key":"2576_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1081\/JDI-120026040","volume":"25","author":"C Rollino","year":"2003","unstructured":"Rollino C, Mazzucco G, Boero R, Beltrame G, Quattrocchio G, Ferro M, Milan M, Berruti S, Quarello F: Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process?. Ren Fail. 2003, 25: 1043-1049. 10.1081\/JDI-120026040.","journal-title":"Ren Fail"},{"key":"2576_CR39","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0272-6386(03)00352-4","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Noel LH, Zuber J, Beaufils H, Martinez F, Lebon P, Papo T, Chauveau D, Bletry O, Grunfeld JP, Piette JC, Lesavre P: The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis. 2003, 41: 1205-1211. 10.1016\/S0272-6386(03)00352-4.","journal-title":"Am J Kidney Dis"},{"key":"2576_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1191\/0961203305lu2058oa","volume":"14","author":"DP D'Cruz","year":"2005","unstructured":"D'Cruz DP: Renal manifestations of the antiphospholipid syndrome. Lupus. 2005, 14: 45-48. 10.1191\/0961203305lu2058oa.","journal-title":"Lupus"},{"key":"2576_CR41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.rdc.2006.05.004","volume":"32","author":"MC Amigo","year":"2006","unstructured":"Amigo MC: Kidney disease in antiphospholipid syndrome. Rheum Dis Clin North Am. 2006, 32: 509-522. 10.1016\/j.rdc.2006.05.004.","journal-title":"Rheum Dis Clin North Am"},{"key":"2576_CR42","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1681\/ASN.2007030257","volume":"18","author":"GS Hill","year":"2007","unstructured":"Hill GS, Nochy D: Antiphospholipid syndrome in systemic lupus erythematosus. J Am Soc Nephrol. 2007, 18: 2461-2464. 10.1681\/ASN.2007030257.","journal-title":"J Am Soc Nephrol"},{"key":"2576_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1440-1797.2007.00792.x","volume":"12","author":"B Cheunsuchon","year":"2007","unstructured":"Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P: Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies. Nephrology (Carlton). 2007, 12: 474-480. 10.1111\/j.1440-1797.2007.00792.x.","journal-title":"Nephrology (Carlton)"},{"key":"2576_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1081\/JDI-120024290","volume":"25","author":"L Fialova","year":"2003","unstructured":"Fialova L, Zima T, Tesar V, Mikulikova L, Malbohan IM, Merta M, Certikova V: Antiphospholipid antibodies in patients with lupus nephritis. Ren Fail. 2003, 25: 747-758. 10.1081\/JDI-120024290.","journal-title":"Ren Fail"},{"key":"2576_CR45","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/rheumatology\/39.9.962","volume":"39","author":"S Loizou","year":"2000","unstructured":"Loizou S, Samarkos M, Norsworthy PJ, Cazabon JK, Walport MJ, Davies KA: Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis. Rheumatology (Oxford). 2000, 39: 962-968. 10.1093\/rheumatology\/39.9.962.","journal-title":"Rheumatology (Oxford)"},{"key":"2576_CR46","first-page":"520","volume":"11","author":"SJ Li","year":"2007","unstructured":"Li SJ, Qian J, Wu MF, Zhang W, Chen XX, Guo Q, Gu YY, Yang CD: The significance of antiphospholipid antibodies against the target antigens in SLE patients with pulmonary arterial hypertension. Clin J Rheumatol. 2007, 11: 520-523.","journal-title":"Clin J Rheumatol"},{"key":"2576_CR47","first-page":"161","volume":"30","author":"J Qian","year":"2007","unstructured":"Qian J, Li SJ, Chen XX, Wang Y, Gu YY, Bao CD, Chen SL, Yang CD: Clinical significance and prevalence of some coagulation-related factors antibodies in patients with antiphospholipid syndrome or systemic lupus erythematosus with thrombosis. Shanghai Med J. 2007, 30: 161-164.","journal-title":"Shanghai Med J"},{"key":"2576_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10875-008-9188-1","volume":"28","author":"V Salle","year":"2008","unstructured":"Salle V, Maziere JC, Smail A, Cevallos R, Maziere C, Fuentes V, Tramier B, Makdassi R, Choukroun G, Vittecoq O, Goeb V, Ducroix JP: Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol. 2008, 28: 291-297. 10.1007\/s10875-008-9188-1.","journal-title":"J Clin Immunol"},{"key":"2576_CR49","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1182\/blood-2004-05-1708","volume":"105","author":"J Zhang","year":"2005","unstructured":"Zhang J, McCrae KR: Annexin A2 mediates endothelial cell activation by antiphospholipid\/anti-beta2 glycoprotein I antibodies. Blood. 2005, 105: 1964-1969. 10.1182\/blood-2004-05-1708.","journal-title":"Blood"},{"key":"2576_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Espinola R, Xiaowei LE, Mao D, Vialpando CG, Salmon JE: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002, 195: 211-220. 10.1084\/jem.200116116.","journal-title":"J Exp Med"},{"key":"2576_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1196\/annals.1361.083","volume":"1051","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Vega-Ostertag M, Liu X, Girardi G: Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. Ann N Y Acad Sci. 2005, 1051: 413-420. 10.1196\/annals.1361.083.","journal-title":"Ann N Y Acad Sci"},{"key":"2576_CR52","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/art.21157","volume":"52","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J: Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum. 2005, 52: 2120-2124. 10.1002\/art.21157.","journal-title":"Arthritis Rheum"},{"key":"2576_CR53","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1681\/ASN.V94590","volume":"9","author":"M Nangaku","year":"1998","unstructured":"Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, Morgan BP, Johnson RJ, Couser WG: CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol. 1998, 9: 590-597.","journal-title":"J Am Soc Nephrol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2736\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:17:15Z","timestamp":1728386235000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,22]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,6]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1186\/ar2736","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,22]]},"assertion":[{"value":"17 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R93"}}